Abortion, InducedNCT00206193
Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
An observational study of Abortion, Induced, run by Atrium Medical Center at 1 site in Netherlands.
Trial summary
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Abortion, Induced
- What is being tested?
- mifepristone, misoprostol and sulprostone
- How many people
- Not given
- Where
- 1 siteNetherlands
- Study dates
- Start not givento not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Adult, Older adult
Who may be able to join
- Pregnant women by whom a termination of pregnancy is desired.
Who cannot join
- Women with liver/kidney disease
- Women on long-term use of corticosteroids (> 6 months)
- Cardiovascular problems
- Therapy-resistant diabetic women
- Therapy-resistant asthma/bronchitis
- Thalassemia
Show all 12Show fewer
- Ulcerative colitis
- Peptic ulcer disease
- Glaucoma
- Porphyria
- Allergic reaction to prostaglandin or mifepristone
- Women with a prior caesarian section or women with contractions at the start of the study
Trial locations and contacts
1 site in 1 country.
F Roumen, Dr. contact
Netherlands1 site, 1 recruiting
- Recruiting
Atrium Medisch Centrum
Heerlen, Limburg
Suzanne HW Vonken, Dr., 045-5766666(6825)
Suzanne HW Vonken, Dr.
About this study
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
- Conditions
- Abortion, Induced
- Being tested
- mifepristone, misoprostol, sulprostone
- Keywords
- termination of pregnancy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mifepristoneDrug
misoprostolDrug
sulprostoneDrug
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2005 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Abortion, InducedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Prospective
Sponsor and investigators
- Lead sponsor
- Atrium Medical Center
- Sponsor type
- University, hospital or other
- Investigators
- F Roumen, Dr., Study director, Atrium Medisch Centrum, Heerlen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00206193
- Sponsor's protocol ID
- TOP-protocol
- Status last verified
- Sep 2005
- First submitted
- 13 Sep 2005
- Last updated
- 30 Oct 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
- ClinicalTrials.gov ID
- NCT00206193
- Acronym / sponsor ID
- TOP-protocol
- Conditions
- Abortion, Induced
- Keywords
- termination of pregnancy
- Study type
- Observational
- Recruitment status
- Unknown status
- Lead sponsor
- Atrium Medical CenterUniversity, hospital or other
- First posted
- 21 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
Study design
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Pregnant women by whom a termination of pregnancy is desired.
Key exclusion criteria (12 listed)
- Women with liver/kidney disease
- Women on long-term use of corticosteroids (> 6 months)
- Cardiovascular problems
- Therapy-resistant diabetic women
- Therapy-resistant asthma/bronchitis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| mifepristone | Drug | – |
| misoprostol | Drug | – |
| sulprostone | Drug | – |
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2007.
Related trials for Abortion, Induced
Not yet recruitingObservational study
Cervical Length Reference Range at 28-34 Weeks in Singleton Pregnancies
Preterm Birth, Cervical Length
Not yet recruiting
Virtual Reality for Pain and Anxiety During Surgical Uterine Evacuation After Early Pregnancy Loss
Early Pregnancy Loss, Procedural Pain
Active, not recruitingObservational study
Factors Influencing Fertility or Pregnancy Health
Menstrual Cycles, Conception
Not yet recruitingPhase 3
Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy Loss
Pregnancy Loss, Pregnancy Loss, Early
Not yet recruitingPhase 4
Azithromycin for Cerclage Prophylaxis
Cervical Insufficiency
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
F Roumen, Dr. contact
F Roumen, Dr. study director
Atrium Medisch Centrum, Heerlen
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Abortion, Induced, run by Atrium Medical Center at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Oct 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Suzanne HW Vonken, Dr. (003145-5766666 ext. 466825, svonken@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2007.